Results for tag: "Larynx Cancer Drug"

The Larynx Cancer Drug market is a subset of the larger Oncology Drugs market. It is composed of drugs used to treat laryngeal cancer, a type of cancer that affects the larynx, or voice box. These drugs are used to reduce the size of tumors, reduce pain, and improve quality of life. Commonly used drugs include chemotherapy, radiation therapy, and targeted therapy. Surgery may also be used to remove tumors. The Larynx Cancer Drug market is highly competitive, with many companies offering innovative treatments. Some of the major players in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more